Indaptus Therapeutics, Inc. (INDP) vs Larimar Therapeutics, Inc. (LRMR)

A side-by-side comparison of Indaptus Therapeutics, Inc. and Larimar Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INDP vs LRMR

growth of $100 · dividends reinvested · last 10y
INDP -100.0% (-57.2%/yr)LRMR -93.1% (-23.5%/yr)LRMR compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $10020182020202220242026$0$7
INDP LRMR

INDP vs LRMR: by the numbers

  • •INDP is the larger company ($293M vs $289M market cap).

Metrics side by side

Valuation

MetricINDPLRMR
P/B ratio25.792.27

Profitability

MetricINDPLRMR
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-135.62%-135.50%
ROIC-129.90%-136.49%

Growth (annualized)

MetricINDPLRMR
Total return CAGR (5Y)-58.32%-23.91%

Frequently asked

How have INDP and LRMR total returns compared?
Over the past 10 years, INDP delivered -57.48% and LRMR delivered -23.59% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.